CLINIBORG
Home
Contents
Recent
Privacy Policy
Terms
About
BARD noninvasive prediction score for advanced fibrosis in nonalcoholic fatty liver
Oct 5, 2014
•
Mark Morgan
categories:
Gastroenterology & Hepatology
BARD noninvasive prediction score for advanced fibrosis in nonalcoholic fatty liver
no (0 points)
YES (1 point)
<-- BMI: 28 or higher
no (0 points)
YES (2 point)
<-- AST to ALT Ratio (AAR): 0.8 or higher
no (0 points)
YES (1 point)
<-- Type 2 Diabetes Mellitus
score -->
number
score1=(Q1)+(Q2)+(Q3)
interpretation -->
result
score2=(Q1)+(Q2)+(Q3);score2>1?'Advanced fibrosis is possible, further evaluation may be needed':'Advanced fibrosis is unlikely, negative predictive value of score is 90-97%'
display/hide references
reference:
#1
Harrison SA, Oliver D, Arnold HL, Gogia S, Neuschwander-Tetri BA. Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Gut. 2008 Oct;57(10):1441-7.
#2
Raszeja-Wyszomirska J, Szymanik B, Ławniczak M, Kajor M, Chwist A, Milkiewicz P, Hartleb M. Validation of the BARD scoring system in Polish patients with nonalcoholic fatty liver disease (NAFLD). BMC Gastroenterol. 2010 Jun 28;10:67.
Calculate The Result!
Reset Form
Result - Copy and paste this output:
Copy to Clipboard
Please enable JavaScript to view the
comments powered by Disqus.